Skip to main content
. 2023 May 12;13(5):e069770. doi: 10.1136/bmjopen-2022-069770

Figure 1.

Figure 1

Patient characteristics as registered during MI hospitalisation for patients attending the 1-year follow-up visit within CR in Sweden 2006–2019. aBMI≥25 kg/m2; bprior MI, PCI, CABG or stroke; cACE inhibitors/ARB, beta blockers, diuretics and/or calcium channel blockers; dstatins and/or ezetimibe. ACEi, ACE inhibitor; ARB, angiotensin receptor blocker; ASCVD, atherosclerotic cardiovascular disease (MI, PCI, CABG or stroke); BMI, body mass index; CABG, coronary artery bypass grafting; MI, myocardial infarction; N, number; PCI, percutaneous coronary intervention.